Arrakis Therapeutics Appoints James Mutamba, PhD, as Chief Business Officer

Go back to Arrakis Therapeutics Appoints James Mutamba, PhD, as Chief Business Officer
(NASDAQ: PYXS) Delayed: 3.23 -0.09 (2.71%)
Previous Close $3.32    52 Week High
Open $3.32    52 Week Low
Day High $3.38    P/E N/A 
Day Low $3.20    EPS
Volume 211,991